Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Am J Ophthalmol. 2021 Jun 30;233:90–100. doi: 10.1016/j.ajo.2021.06.022

Table 1:

Population demographics, comorbidities, and medications

Demographics Subjects (n=10)
Age, years, mean ± SD (range) 60.4 ± 4.2 (51–66)
Gender, male, n (%) 3 (30%)
Race, white, n (%) 5 (50%)
Ethnicity, Hispanic, n (%) 4 (40%)
Past smoker, n (%) 2 (20%)
Current smoker, n (%) 1 (10%)
Comorbidities
Hypertension, n (%) 4 (40%)
Diabetes, n (%) 2 (20%)
Medications
Anti-hypertensive 5 (50%)
Lipid lowering 1 (10%)
Glucose lowering 1 (10%)
Analgesic 9 (90%)
Anti-depressant 2 (20%)
Anxiolytic 2 (20%)
Anti-histamine 2 (20%)
Oral Antibiotics 1 (10%)
Topical Medications
Artificial Tears 10 (100%)
Topical cyclosporine 0.05% 6 (60%)
Lifitegrast 5% 3 (30%)
Autologous Serum Tears 3 (30%)
Topical Corticosteroid 2 (20%)
Topical Antibiotic 1 (10%)
Punctal Plug 4 (40%)

SD=standard deviation, n=number in group